CD40LG and psychotic disorder: Only one of 9 subjects who developed de novo NSAbs at follow-up became psychotic: this subject developed NMDAR IgM antibodies (1:10) a year after initial assessment, having been seronegative at baseline; he went on to transition to psychosis a year later, but no blood samples were available at the time he became psychotic or afterwards.